Leah Rush

Stock Analyst at Brookline Capital

(2.55)

# 2,202

Out of 5,148 analysts

2

Total ratings

100%

Success rate

27.94%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Leah Rush

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CCCC C4 Therapeutics	Maintains: Buy	$20 → $30	$3.17	+846.37%	1	Feb 23, 2026
	EXEL Exelixis	Initiates: Buy	n/a	$41.03	-	1	Dec 23, 2024

C4 Therapeutics

Feb 23, 2026

Maintains: Buy

Price Target: $20 → $30

Current: $3.17

Upside: +846.37%

Exelixis

Dec 23, 2024

Initiates: Buy

Price Target: n/a

Current: $41.03

Upside: -